Valsil

Valsil may be available in the countries listed below.

Ingredient matches for Valsil

Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Valsil in the following countries:

• Germany

International Drug Name Search

Simavas

Simavas may be available in the countries listed below.

Ingredient matches for Simavas

Simvastatin

Simvastatin is reported as an ingredient of Simavas in the following countries:

• Vietnam

International Drug Name Search

Brompheniramine 24-Hour Sustained-Release Capsules

Pronunciation: brome-fen-EER-a-meen
Generic Name: Brompheniramine
Brand Name: Lodrane 24

Brompheniramine 24-Hour Sustained-Release Capsules are used for:

Treating and preventing symptoms of hay fever, other allergies, and colds. It may also be used for other conditions as determined by your doctor.

Brompheniramine 24-Hour Sustained-Release Capsules are an antihistamine. It works by blocking the action of histamine, a chemical released during allergic reactions.

Do NOT use Brompheniramine 24-Hour Sustained-Release Capsules if:

• you are allergic to any ingredient in Brompheniramine 24-Hour Sustained-Release Capsules


• you are breast-feeding


• you have narrow-angle glaucoma, or a peptic or stomach ulcer


• you are unable to urinate or you are having an asthma attack


• you are taking sodium oxybate (GHB) or you have taken a monoamine oxidase (MAO) inhibitor (eg, phenelzine) in the past 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Brompheniramine 24-Hour Sustained-Release Capsules:

Some medical conditions may interact with Brompheniramine 24-Hour Sustained-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have an enlarged prostate, difficulty urinating or severe constipation


• if you have an overactive thyroid, asthma, increased pressure in the eyes, glaucoma, heart disease, or high blood pressure

Some MEDICINES MAY INTERACT with Brompheniramine 24-Hour Sustained-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Barbiturates (eg, phenobarbital), MAO inhibitors (eg, phenelzine), sodium oxybate (GHB), or tricyclic antidepressants (eg, amitriptyline) because the risk of severe drowsiness may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Brompheniramine 24-Hour Sustained-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Brompheniramine 24-Hour Sustained-Release Capsules:

Use Brompheniramine 24-Hour Sustained-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Brompheniramine 24-Hour Sustained-Release Capsules may be taken with food if it upsets your stomach.


• Swallow whole. Do not break, crush, or chew before swallowing.


• If you miss a dose of Brompheniramine 24-Hour Sustained-Release Capsules, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Brompheniramine 24-Hour Sustained-Release Capsules.

Important safety information:

• Brompheniramine 24-Hour Sustained-Release Capsules may cause dizziness or drowsiness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Brompheniramine 24-Hour Sustained-Release Capsules. Using Brompheniramine 24-Hour Sustained-Release Capsules alone, with certain other medicines, or with alcohol may lessen your ability to drive or to perform other potentially dangerous tasks.


• Avoid drinking alcohol or taking other medicines that cause drowsiness (eg, sedatives, tranquilizers) while taking Brompheniramine 24-Hour Sustained-Release Capsules. Brompheniramine 24-Hour Sustained-Release Capsules will add to the effects of alcohol and other depressants. Ask your pharmacist if you have questions about which medicines are depressants.


• Risk of side effects may be increased with high doses or prolonged use. Do NOT exceed the recommended dose or take Brompheniramine 24-Hour Sustained-Release Capsules for longer than prescribed without checking with your doctor.


• Use Brompheniramine 24-Hour Sustained-Release Capsules with caution in the ELDERLY because they may be more sensitive to its effects, especially dizziness, drowsiness, dry mouth, and trouble urinating.


• Use Brompheniramine 24-Hour Sustained-Release Capsules with extreme caution in CHILDREN. Safety and effectiveness have not been confirmed.


• Brompheniramine 24-Hour Sustained-Release Capsules may interfere with results of some lab tests, including allergy skin tests. Inform lab attendants that you are taking Brompheniramine 24-Hour Sustained-Release Capsules.


• PREGNANCY and BREAST-FEEDING: It is unknown if Brompheniramine 24-Hour Sustained-Release Capsules can cause harm to the fetus. If you become pregnant while taking Brompheniramine 24-Hour Sustained-Release Capsules, discuss with your doctor the benefits and risks of using Brompheniramine 24-Hour Sustained-Release Capsules during pregnancy. It is unknown if Brompheniramine 24-Hour Sustained-Release Capsules are excreted in breast milk. Do not breast-feed while taking Brompheniramine 24-Hour Sustained-Release Capsules.

Possible side effects of Brompheniramine 24-Hour Sustained-Release Capsules:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Dizziness; drowsiness; dry mouth, throat, and nose; thickening of mucus in nose or throat.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fast or irregular heartbeat; fever; mental or mood changes; shortness of breath; sore throat; unusual bleeding or bruising; unusual tiredness or weakness.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Brompheniramine side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include bizarre behavior; constipation; enlarged pupils; excitement; flushing; hallucinations; seizures; severe dizziness; severe drowsiness.

Proper storage of Brompheniramine 24-Hour Sustained-Release Capsules:

Store Brompheniramine 24-Hour Sustained-Release Capsules at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Keep Brompheniramine 24-Hour Sustained-Release Capsules out of the reach of children and away from pets.

General information:

• If you have any questions about Brompheniramine 24-Hour Sustained-Release Capsules, please talk with your doctor, pharmacist, or other health care provider.


• Brompheniramine 24-Hour Sustained-Release Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Brompheniramine 24-Hour Sustained-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Brompheniramine resources

• Brompheniramine Side Effects (in more detail)
• Brompheniramine Use in Pregnancy & Breastfeeding
• Drug Images
• Brompheniramine Drug Interactions
• Brompheniramine Support Group
• 6 Reviews for Brompheniramine - Add your own review/rating

Compare Brompheniramine with other medications

• Allergic Reactions
• Cold Symptoms
• Hay Fever
• Urticaria

Fionicol

Fionicol may be available in the countries listed below.

Ingredient matches for Fionicol

Chloramphenicol

Chloramphenicol is reported as an ingredient of Fionicol in the following countries:

• Bangladesh

International Drug Name Search

Reumoxican

Reumoxican may be available in the countries listed below.

Ingredient matches for Reumoxican

Piroxicam

Piroxicam is reported as an ingredient of Reumoxican in the following countries:

• Portugal

International Drug Name Search

Edilox-S

Edilox-S may be available in the countries listed below.

Ingredient matches for Edilox-S

Ofloxacin

Ofloxacin is reported as an ingredient of Edilox-S in the following countries:

• India

Serrapeptase

Serrapeptase is reported as an ingredient of Edilox-S in the following countries:

• India

International Drug Name Search

Apo-Trimip

Apo-Trimip may be available in the countries listed below.

Ingredient matches for Apo-Trimip

Trimipramine

Trimipramine maleate (a derivative of Trimipramine) is reported as an ingredient of Apo-Trimip in the following countries:

• Canada

International Drug Name Search

Phavi

Phavi may be available in the countries listed below.

Ingredient matches for Phavi

Fluticasone

Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Phavi in the following countries:

• Japan

International Drug Name Search

Sulfarlem S25

Sulfarlem S25 may be available in the countries listed below.

Ingredient matches for Sulfarlem S25

Anetholtrithion

Anetholtrithion is reported as an ingredient of Sulfarlem S25 in the following countries:

• Belgium


• France


• Luxembourg


• Switzerland

International Drug Name Search

Tifaxin

Tifaxin may be available in the countries listed below.

Ingredient matches for Tifaxin

Venlafaxine

Venlafaxine is reported as an ingredient of Tifaxin in the following countries:

• Bulgaria

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Tifaxin in the following countries:

• Slovakia

International Drug Name Search